Philips Fights Investor Discovery Request in Austin Federal Court
Philips is contesting in U.S. District Court in Austin a bid by foreign investors to depose its former director of medical affairs, tied to sleep-apnea CPAP and BiPAP issues. Regulators cited 116,000 device reports and up to 560 deaths linked to foam. Philips recalled 15 million devices, stopped U.S. sales, and has paid $1.69 billion to consumers as investor suits seek over $1 billion.